Page 34 - P4304.1-V102_PS Magazine - Nov 24

Inclisiran (Leqvio) and

Drug Tariff Part VIIIC

By Caroline Pond

Part VIIIC – Arrangements of
payment for products supplied
free of charge or products with
a nominal price

In September 2021, the Drug Tariff was Inclisiran is a cholesterol lowering
updated to include a new section, Part treatment indicated for adults with primary
VIIIC. Part VIIIC sets out arrangements hypercholesterolaemia (heterozygous familial
of payment for products with a and non-familial) or mixed dyslipidaemia.
Novartis is the manufacturer, and they are
nominal price (i.e where the purchase working collaboratively with NHSE&I to
price of the product is significantly improve patient pathways to support improved
lower than its NHS list price). lipid management, which is one of the
priorities set out in the NHS Long Term Plan.
Products listed in Part VIIIC are available at
nominal prices or free-of-charge because Inclisiran has been identified by NHSE&I as a
of commercial deals in place between treatment it wishes to adopt systematically
the manufacturer or supplier and NHS and at scale to help tackle cardiovascular
England/ NHS Improvement (NHSE&I). disease (CVD) in a large high-risk patient
These arrangements allow manufacturers to population who are unable to reach their
supply a drug to the NHS at a reduced cost LDL-C goals on maximum tolerated lipid
compared to the published NHS list prices lowering therapies such as statins. To achieve
as detailed in the Dictionary of Medicines the scale and volumes required to positively
and Devices (dm+d). impact a nation’s cardiovascular health
outcomes, the initiation and management of
What types of products are this treatment will be predominantly carried
listed in Part VIIIC? out within a primary care setting, hence you

Part VIIIC includes products that are are seeing prescriptions for Inclisaran or its
brand name Leqvio..
available from a manufacturer or supplier at
a nominal price that is significantly below Usually dispensing contractors would be
the NHS list price for the product because of reimbursed the NHS list price for Inclisiran if
a commercial arrangement between NHSE&I it was listed in Part VIIIA of the Drug Tariff or
and the manufacturer or supplier of the at the Brand price for Leqvio which currently
product. stands at £1987.36 (Sept 24).
One of those items is Inclisiran (Leqvio) As it would not represent value for money
and I know, from the number of emails I am for the NHS and the taxpayer to reimburse
receiving, this is catching some of you out contractors the NHS list price for Leqvio/
as we begin to process more prescriptions in Inclisiran and in order to implement this
primary care. treatment at an affordable price and limit

34 P S M a g a z i n e | I n c l i s i r a n (L e q v i o ) a n d D B u y d i r e c t o n l i n e a t P S U K . co . u k
34
Buy direct online at PSUK.co.uk
PS Magazine | MDS Terms Informationrug Tariff Part VIIIC
09/10/2024 14:34:58
P4304.1-V103_PS Magazine - November 244.indd 34 09/10/2024 14:34:58
P4304.1-V103_PS Magazine - November 244.indd 34